Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Development of an in Vitro Screening Model for the Biosynthesis of Acyl Glucuronide Metabolites and the Assessment of Their Reactivity toward Human Serum Albumin

Sebastien Bolze, Norbert Bromet, Croisine Gay-Feutry, Frederic Massiere, Roselyne Boulieu and Thierry Hulot
Drug Metabolism and Disposition April 2002, 30 (4) 404-413; DOI: https://doi.org/10.1124/dmd.30.4.404
Sebastien Bolze
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Bromet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Croisine Gay-Feutry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic Massiere
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roselyne Boulieu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Hulot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 30 no. 4 404-413
DOI 
https://doi.org/10.1124/dmd.30.4.404
PubMed 
11901094

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 11, 2001
  • Accepted December 24, 2001
  • Published online April 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Sebastien Bolze1,
  2. Norbert Bromet2,
  3. Croisine Gay-Feutry3,
  4. Frederic Massiere3,
  5. Roselyne Boulieu4 and
  6. Thierry Hulot1
  1. 1Department of Pharmacokinetics and Metabolism, Lipha S.A., Centre de Recherche Lyon-Lacassagne, Lyon, France (S.B., T.H.); 2Biotec Centre, Orleans, France (N.B.); 3Biopredic International, Rennes, France (C.G.F., F.M.); and 4Département de Pharmacie Clinique, de Pharmacocinétique et Évaluation des Médicaments, Faculté de Pharmacie, Université Lyon, France (R.B.)
  1. Sébastien Bolze, MPK department, LIPHA S.A., 115 Av. Lacassagne, 69003 Lyon, France. E-mail:sebastien.bolze{at}lipha.fr
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to September 2023

AbstractFullPdf
Aug 20170129
Sep 201723919
Oct 20170197
Nov 20170319
Dec 20174127
Jan 201832112
Feb 20181134
Mar 20181166
Apr 20181229
May 20185186
Jun 20181235
Jul 201821012
Aug 2018363
Sep 20182165
Oct 2018298
Nov 2018183
Dec 20181233
Jan 20191343
Feb 2019433
Mar 20192531
Apr 20191541
May 20191610
Jun 2019815
Jul 20191211
Aug 201948214
Oct 20191420
Nov 20192101
Dec 20193343
Jan 20201531
Feb 2020900
Mar 20201953
May 20201352
Jun 20201511
Jul 20201113
Aug 20202065
Sep 20201453
Oct 20202002
Nov 2020922
Dec 20201241
Jan 202122142
Feb 20219136
Mar 20211361
Apr 2021732
May 20211283
Jun 2021882
Jul 20211787
Aug 20211151
Sep 20211131
Oct 20211854
Nov 2021632
Dec 20212621
Jan 2022545
Feb 2022654
Mar 20221241
Apr 20221233
May 20222622
Jun 20221531
Jul 20221210
Aug 2022821
Sep 2022762
Oct 20221411
Nov 20221832
Dec 20224332
Jan 20233543
Feb 2023521
Mar 2023431
Apr 20231055
May 20233183
Jun 20231110
Jul 20232230
Aug 2023930
Sep 20231010

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (4)
Drug Metabolism and Disposition
Vol. 30, Issue 4
1 Apr 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Development of an in Vitro Screening Model for the Biosynthesis of Acyl Glucuronide Metabolites and the Assessment of Their Reactivity toward Human Serum Albumin
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Development of an in Vitro Screening Model for the Biosynthesis of Acyl Glucuronide Metabolites and the Assessment of Their Reactivity toward Human Serum Albumin

Sebastien Bolze, Norbert Bromet, Croisine Gay-Feutry, Frederic Massiere, Roselyne Boulieu and Thierry Hulot
Drug Metabolism and Disposition April 1, 2002, 30 (4) 404-413; DOI: https://doi.org/10.1124/dmd.30.4.404

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Development of an in Vitro Screening Model for the Biosynthesis of Acyl Glucuronide Metabolites and the Assessment of Their Reactivity toward Human Serum Albumin

Sebastien Bolze, Norbert Bromet, Croisine Gay-Feutry, Frederic Massiere, Roselyne Boulieu and Thierry Hulot
Drug Metabolism and Disposition April 1, 2002, 30 (4) 404-413; DOI: https://doi.org/10.1124/dmd.30.4.404
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Ontogeny of CPPGL
  • Expression of AKR and SDR Isoforms in the Human Intestine
  • Metabolism of Lufotrelvir in Humans
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics